Table 1 Patient characteristics within subgroups.
Characteristic | Delayed days ≤90 (n = 792) | Delayed days >90 (n = 292) | P* |
|---|---|---|---|
Age, years | Â | Â | 0.001 |
  Mean ± SD | 47.84 ± 13.67 | 44.92 ± 11.71 |  |
Menstrual status, No. (%) | Â | Â | 0.346 |
  Premenopausal | 443 (55.93) | 175 (59.93) |  |
  Postmenopausal | 309 (39.02) | 100 (34.25) |  |
  Unknown | 40 (5.05) | 17 (5.82) |  |
Residence, No. (%) | Â | Â | 0.024 |
  Urban | 446 (56.31) | 142 (48.63) |  |
  Rural | 346 (43.69) | 150 (51.37) |  |
Education, No. (%) | Â | Â | 0.021 |
  ≥High school | 498 (62.88) | 161 (55.14) |  |
  <High school | 294 (37.12) | 131 (44.86) |  |
Marital status, No. (%) | Â | Â | 0.875 |
  Married | 583(73.61) | 215(73.63) |  |
  Unmarried | 115(14.52) | 45 (15.41) |  |
  Other | 94(11.87) | 32 (10.96) |  |
Screening detection places, No. (%) | Â | Â | 0.006 |
  PUMCH | 389 (49.12) | 116 (39.73) |  |
  Other institutions | 403 (50.88) | 176 (60.27) |  |
Tumor size, No. (%) | Â | Â | 0.482 |
  T1 | 680 (85.86) | 252 (86.30) |  |
  T2 | 96 (12.12) | 31 (10.62) |  |
  T3 | 16 (2.02) | 9 (3.08) |  |
Tumor grade, No. (%) | Â | Â | 0.071 |
  G1 | 261 (32.95) | 75 (25.68) |  |
  G2 | 314 (39.65) | 129 (44.18) |  |
  G3 | 217 (27.40) | 88 (30.14) |  |
Molecular subtype, No. (%) | Â | Â | 0.095 |
  Luminal A | 372 (46.97) | 151 (51.71) |  |
  Luminal B | 182 (22.98) | 70 (23.97) |  |
  Triple Negative | 158 (19.95) | 55 (18.84) |  |
  Her-2+ | 80(10.10) | 16(5.48) |  |
Axillary node metastasis, No. (%) | Â | Â | 0.360 |
  No | 682 (86.11) | 245 (83.90) |  |
  Yes | 110 (13.89) | 47 (16.10) |  |
Comorbid conditions, No. (%) | Â | Â | 0.198 |
  Yes | 146(18.43) | 64(21.92) |  |
  No | 646(81.57) | 228(78.08) |  |
Breast cancer family history, No. (%) | Â | Â | 0.789 |
  Yes | 58(7.32) | 20(6.85) |  |
  No | 734(92.68) | 272(93.15) |  |
